‘Metro Mentor' moment: Kiran Mazumdar-Shaw ditches car, hops on Bengaluru Metro with Exxon Mobil's ‘Iron Lady'; calls ride ‘quick way to avoid traffic'
Biocon's Kiran Mazumdar-Shaw swapped her car for Bengaluru's Namma Metro Purple Line, traveling from Whitefield to Vidhana Soudha to dodge the city's notorious traffic.
BENGALURU: Biocon founder Kiran Mazumdar-Shaw left her luxury wheels behind on Tuesday to board the
Namma Metro
Purple Line.
The ride, which she took from Whitefield to Vidhana Soudha, was part of her attempt to sidestep the city's infamous traffic snarls—and it seems to have worked.
In a post on social media platform X, Shaw described the journey as a 'great ride' and gave a shout-out to the Bangalore Metro Rail Corporation Limited (BMRCL) for the smooth experience. Accompanying her on the trip was Jennifer Erich, who she fondly referred to as her 'Namma Metro friend' and the 'Iron Lady at Exxon Mobil.'
'Took the Purple Line from Whitefield to Vidhana with my Namma Metro friend @jennifer_erich, the Iron Lady of Exxon Mobil.
Such a quick way to avoid traffic. Great ride. Thanks @OfficialBMRCL,' Shaw posted.
'So happy to be your Metro Mentor'
Erich replied: 'So happy to be your Metro Mentor!! Thanks so much for joining me at my office today.'
The post quickly caught the attention of netizens, with many praising Shaw for leading by example. "Great! A society's progress is measured when the Elite and powerful Like you take public transport for travel. Really commendable and exemplary" wrote one user.
Another added,'A developed country is not a place where the poor have cars. It's where the rich use public transportation.- Gustavo Petro'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Deccan Herald
19 hours ago
- Deccan Herald
Centre asks for tweaking Metro Phase 3A's 'high' cost
The 36.59-km Phase 3A, also called the Red Line, will connect Sarjapur in southeastern Bengaluru to Hebbal in the north. It is estimated to cost Rs 28,405 crore, or Rs 776.3 crore per km, the most expensive in Namma Metro's history.
Mint
a day ago
- Mint
Top 5 First-Generation Women Wealth Creators. Hint it's not Indra K Nooyi
Indian and India-origin women entrepreneurs are constantly shaping the business ecosystem around the world as they build their billion-dollar businesses. The Candere Hurun India Women Leaders List 2025 has showcased the top first-generation self-made wealth creators. Radha Vembu, Kiran Mazumdar-Shaw, Indra K Nooyi, and Meena Sethi were among many other prominent industry names of the top women entrepreneurs who have successfully become the first generation of self-made wealth creators in their families. The data also highlighted that the 'Software and Services' segment was the most dominant sector for these women entrepreneurs, which contributed nearly ₹ 1.11 lakh crore. Retail, finance, healthcare, and media were among the other leading sectors. 1. Radha Vembu: Ranking top of the list is Radha Vembu, an Indian billionaire businesswoman who owns the cloud-based business software multinational giant Zoho Corporation. According to the list, Vembu's wealth stands at ₹ 55,300 crore at the age of 52 years. Radha Vembu is married to Sridhar Vembu and lives at Chengalpattu, near Chennai, Tamil Nadu. 2. Jayshree Ullal: Jayshree Ullal is an Indian-origin British-born billionaire businesswoman who is also the Chief Executive Officer (CEO) and President of Arista Networks, a software services firm. 63-year-old Jayshree Ullal ranked second in the list with her wealth estimated to be around ₹ 48,900 crore, according to the Hurun India list. The CEO is based out of Santa Clara, California, from where she runs the cloud networking company, which designs and sells multiple software products. 3. Kiran Mazumdar-Shaw & Family: The founder of Bengaluru-based biotechnology and biopharmaceutical giant Kiran Mazumdar-Shaw ranked third in the Candere Hurun India Women Leaders List 2025, and her wealth is estimated to be around ₹ 32,000 crore. The 71-year-old industry veteran is based out of Bengaluru and has played a key role in developing India's healthcare industry with the help of her company, Biocon. 4. Falguni Nayar & Family: Online beauty brand Nykaa's (FSN E-Commerce Ventures) founder and CEO, Falguni Nayar, successfully ranked fourth on the Hurun India list with her wealth estimated to be at ₹ 29,000 crore. The 61-year-old CEO is based in Mumbai and has played a major role in developing India's online beauty segment by founding Nykaa with her own money. As of 4 June 2025, the company is listed on the Indian stock market with a market capitalisation (M-Cap) of ₹ 55,721.18 crore. 5. Neha Narkhede & Family: Palo Alto-based Neha Narkhede is the co-founder of the software and service firm Confluent. Narkhede is an Indian-born American whose wealth is estimated to be around ₹ 6,800 crore, which marked her at the fifth rank in the Hurun India list. Other members in the list were Upstox's Kavitha Subramanian at wealth worth ₹ 6,500 crore, Lenskart's Neha Bansal at ₹ 5,100 crore, Former CEO of Pepsico Indra K Nooyi at ₹ 4,800 crore, Knight Riders Sports' Juhi Chawla and family at ₹ 4,500 crore, and lastly, ranking 10th on the Candere Hurun India Women Leaders List 2025 was Meena Sethi and family at an estimated wealth of ₹ 2,700 crore.
Hans India
2 days ago
- Hans India
Biocon gets CDSCO nod for generic diabetes drug
New Delhi: Biocon on Tuesday said it received approval from the government authorities for a generic diabetes medication – Liraglutide drug substance. Itswholly-owned subsidiary Biocon Pharma has received approval for its Liraglutide drug product (6 mg/ml solution for injection in pre-filled pen and cartridge), from the Drugs Controller General of India (CDSCO). The approval is for the generic version of Victoza, indicated for the treatment of insufficiently controlled Type 2 Diabetes Mellitus in adults, adolescents and children aged 10 years and above, as an adjunct to diet and exercise, the company said in a regulatory filing. "The approval of our first vertically integrated GLP-1 in India, Liraglutide, is another significant step forward in expanding access of this product to patients suffering from diabetes," Biocon CEO and MD Siddharth Mittal said. India has one of the highest number of people with diabetes globally, with estimates exceeding 77 million cases, and expected to rise further, he added. "We are now gearing up to launch the product expeditiously through our commercialisation partners in India," Mittal stated.
